ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 84 filers reported holding ADICET BIO INC in Q3 2023. The put-call ratio across all filers is 7.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,291,169 | -43.5% | 1,672,386 | +0.2% | 0.00% | – |
| Q2 2023 | $4,054,908 | -58.4% | 1,668,686 | -1.3% | 0.00% | – |
| Q1 2023 | $9,737,102 | -35.6% | 1,690,469 | -0.0% | 0.00% | – |
| Q4 2022 | $15,118,362 | -29.1% | 1,691,092 | +12.8% | 0.00% | -100.0% |
| Q3 2022 | $21,319,000 | +18.2% | 1,499,259 | +21.4% | 0.00% | 0.0% |
| Q2 2022 | $18,034,000 | -15.7% | 1,235,210 | +15.3% | 0.00% | 0.0% |
| Q1 2022 | $21,401,000 | -1.9% | 1,071,655 | -14.1% | 0.00% | – |
| Q4 2021 | $21,812,000 | +160.8% | 1,247,133 | +16.9% | 0.00% | – |
| Q3 2021 | $8,364,000 | -23.4% | 1,066,819 | +0.6% | 0.00% | – |
| Q2 2021 | $10,916,000 | +3.3% | 1,060,821 | +31.3% | 0.00% | – |
| Q1 2021 | $10,569,000 | +106.6% | 807,988 | +121.9% | 0.00% | – |
| Q4 2020 | $5,115,000 | +358.7% | 364,141 | +288.2% | 0.00% | – |
| Q3 2020 | $1,115,000 | – | 93,808 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |